Orthofix Medical (OFIX) Change in Accured Expenses (2016 - 2026)
Orthofix Medical has reported Change in Accured Expenses over the past 16 years, most recently at -$5.2 million for Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 75.59% year-over-year to -$5.2 million, compared with a TTM value of $13.9 million through Mar 2026, up 363.51%, and an annual FY2025 reading of -$2.3 million, down 123.81% over the prior year.
- Change in Accured Expenses came in at -$5.2 million for Q1 2026, down from $6.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $12.7 million in Q3 2025 to a low of -$21.4 million in Q1 2025.
- Median Change in Accured Expenses over the past 5 years was $2.9 million (2022), compared with a mean of $396117.6.
- The sharpest move saw Change in Accured Expenses crashed 161.67% in 2022, then soared 936.88% in 2024.
- Over 5 years, Change in Accured Expenses stood at $5.2 million in 2022, then decreased by 21.34% to $4.1 million in 2023, then soared by 203.18% to $12.4 million in 2024, then crashed by 45.28% to $6.8 million in 2025, then crashed by 176.96% to -$5.2 million in 2026.
- Per Business Quant, the three most recent readings for OFIX's Change in Accured Expenses are -$5.2 million (Q1 2026), $6.8 million (Q4 2025), and $12.7 million (Q3 2025).